Oppenheimer & Co. Inc. Invests $624,000 in Everus (NYSE:ECG)

Oppenheimer & Co. Inc. purchased a new position in shares of Everus (NYSE:ECG - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,483 shares of the company's stock, valued at approximately $624,000.

A number of other large investors also recently modified their holdings of ECG. Hennessy Advisors Inc. bought a new stake in shares of Everus in the fourth quarter worth $31,611,000. Principal Financial Group Inc. acquired a new position in Everus during the 4th quarter worth about $16,241,000. Moody Aldrich Partners LLC bought a new stake in shares of Everus in the 4th quarter valued at about $4,359,000. New York State Common Retirement Fund acquired a new stake in shares of Everus in the fourth quarter valued at about $3,472,000. Finally, Register Financial Advisors LLC bought a new position in shares of Everus during the fourth quarter worth about $3,167,000.

Insider Buying and Selling at Everus

In other Everus news, Director Rocca Michael Della bought 1,050 shares of the firm's stock in a transaction dated Tuesday, February 18th. The stock was bought at an average cost of $47.56 per share, with a total value of $49,938.00. Following the completion of the transaction, the director now directly owns 2,027 shares in the company, valued at approximately $96,404.12. The trade was a 107.47 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Maximillian J. Marcy purchased 1,300 shares of the company's stock in a transaction that occurred on Tuesday, February 25th. The stock was acquired at an average cost of $38.99 per share, for a total transaction of $50,687.00. Following the transaction, the chief financial officer now owns 5,508 shares in the company, valued at $214,756.92. This represents a 30.89 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 3,750 shares of company stock valued at $153,853.

Remove Ads

Analyst Ratings Changes

Several brokerages recently commented on ECG. Wolfe Research began coverage on Everus in a report on Tuesday, December 3rd. They issued a "peer perform" rating on the stock. Oppenheimer upped their price objective on shares of Everus from $70.00 to $80.00 and gave the company an "outperform" rating in a research note on Tuesday, January 7th. Finally, Stifel Nicolaus lowered their target price on shares of Everus from $85.00 to $67.00 and set a "buy" rating for the company in a research note on Thursday, February 13th.

Everus Trading Down 4.0 %

ECG stock traded down $1.62 during mid-day trading on Monday, reaching $38.36. The company's stock had a trading volume of 840,365 shares, compared to its average volume of 714,944. Everus has a 12 month low of $37.18 and a 12 month high of $77.93. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.50 and a current ratio of 1.58. The business's 50 day moving average price is $60.08.

Everus (NYSE:ECG - Get Free Report) last released its quarterly earnings data on Tuesday, February 11th. The company reported $0.67 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.73 by ($0.06). Research analysts forecast that Everus will post 2.49 earnings per share for the current year.

Everus Company Profile

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.